QQ客服 官方微博 反馈留言

	Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis
	Hu, Li-Peng; Zhang, Xiao-Xin; Jiang, Shu-Heng; Tao, Ling-Ye; Li, Qing; Zhu, Li-Li; Yang, Ming-Wei; Huo, Yan-Miao; Jiang, Yong-Sheng; Tian, Guang-Ang
刊名	CLINICAL CANCER RESEARCH
	2019
卷号	25页码:1318-1330
关键词	adenosine triphosphate ar c118925xx gemcitabine glucose transporter 1 hypoxia inducible factor 1alpha Myc protein platelet derived growth factor beta receptor platelet derived growth factor receptor protein kinase Yes purinergic P2Y receptor antagonist purinergic P2Y2 receptor unclassified drug Yes1 protein, Akt signaling animal experiment animal model animal tissue Article cancer inhibition cancer prognosis cancer staging controlled study drug potentiation glycolysis human human cell human tissue inflammation lymph node metastasis male mouse mouse model nonhuman overall survival pancreas adenocarcinoma pancreatic ductal carcinoma cell line Pi3K/Akt signaling priority journal RNA sequence tumor classification tumor differentiation tumor microenvironment tumor volume tumor xenograft
ISSN号	1078-0432
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3221654
专题	大连理工大学
作者单位	1.Shanghai Jiao Tong Univ, Sch Biomed Engn, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China. 2.Shanghai Jiao Tong Univ, Shanghai Canc Inst, Sch Med, Ren Ji Hosp, 800 Dongchuan Rd, Shanghai 200240, Peoples R China. 3.Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Biliary Pancreat Surg, Shanghai, Peoples R China. 4.Dalian Univ Technol, Sch Pharmaceut Sci & Technol, Dalian, Peoples R China.,Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Funct Genom & Prote Lab, Omaha, NE USA. 5.Shanghai Jiao Tong Univ, Sch Biomed Engn, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China. 6.Shanghai Jiao Tong Univ, Shanghai Canc Inst, Sch Med, Ren Ji Hosp, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
推荐引用方式 GB/T 7714	Hu, Li-Peng,Zhang, Xiao-Xin,Jiang, Shu-Heng,et al. Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis[J]. CLINICAL CANCER RESEARCH,2019,25:1318-1330.
APA	Hu, Li-Peng.,Zhang, Xiao-Xin.,Jiang, Shu-Heng.,Tao, Ling-Ye.,Li, Qing.,...&Zhang, Zhi-Gang.(2019).Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis.CLINICAL CANCER RESEARCH,25,1318-1330.
MLA	Hu, Li-Peng,et al."Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis".CLINICAL CANCER RESEARCH 25(2019):1318-1330.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。